Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (406)	11/12/1998 4:50:00 AM
From: kas1	Read Replies (1) \| Respond to of 642

right on -- there seems to be an entire backlash of people who are so uncomfortable with depression patients being healed or helped instead of suffering "punishment" for their "weakness"... consider the fact that most depression patients are female and young, and that psychopharmacology stands as a distinct alternative to seeking help from established authority forces when depressed, and the sociopolitical agenda here seems quite clear. it's like something out of reader's digest. find a few outliers who had bad experiences with prozac and make a big deal out of their stories to "prove" your point. maybe even more interesting though are the people who claim ssri's are "unnatural" and instead advocate the use of "natural" substances like st john's wort... and because sj's w is "herbal" it of course "contains no chemicals," never mind that it acts as a monoamine oxidase inhibitor, a generaly more dangerous class of drugs than ssri's... back to the subject of lilly. every new book that comes out on this topic, pro or con, will do more to publicize and ingrain the brand name prozac, which is certainly helpful once the generics start popping up.